Kidswell Bio Corporation [4584.T]
TOKYO, Jun 01 (Pulse News Wire) – Kidswell Bio Corporation (4584.T) disclosed the exercise status for its fourth series of convertible bonds and the 23rd issuance of warrants for the month of May 2026. No shares were delivered during the observation period for the fourth series of convertible bonds.
The total amount exercised was ¥0 million, representing a 0% utilization rate compared to the outstanding balance. As of the end of April, there was a residual unexercised amount of ¥125 million, which decreased to ¥125 million by the end of May. There were no significant events related to the bond exercises during the month. Regarding the 23rd issuance of warrants, no warrants were exercised during the month of May.
At the end of April, there were 13,746 unexercised warrants remaining, equivalent to 1,374,600 shares. By the end of May, this number remained unchanged at 13,746 warrants, still equating to 1,374,600 shares. No notable activities occurred concerning warrant exercises during the month. In addition, the company adhered to the exercise limitations set forth by the Tokyo Stock Exchange's Securities Listing Regulations Article 434 and the Japan Securities Dealers Association’s regulations on third-party allotments, ensuring compliance throughout the period.
🟢 Confidence: High AI-translated content.